BNR · Burning Rock Biotech Ltd
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-07-02 |
Burning Rock Announces Founder’s Purchase of Its ADSs
GUANGZHOU, China, July 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its founder, chairman of the |
| 2026-06-09 |
Burning Rock Reports First Quarter 2026 Financial Results
GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three |
| 2026-04-28 |
Burning Rock Publishes 2025 Annual Report on Form 20-F
GUANGZHOU, China, April 28, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing technology in the field of precision oncology, announces that on April 28, 2026 it filed its Annual |
| 2026-04-02 |
Burning Rock Announces Founder’s Purchase of Its ADSs
GUANGZHOU, China, April 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its founder, chairman of |
| 2026-03-12 |
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
GUANGZHOU, China, March 12, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported unaudited financial results for |
| 2026-01-05 |
Burning Rock Announces Founder`s Purchase of Its ADSs
GUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that as of the date of this press |
| 2025-12-23 |
Burning Rock Announces Results of 2025 Annual General Meeting
GUANGZHOU, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “ Company ” or “ Burning Rock ”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder |
| 2025-12-01 |
Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025
GUANGZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “ Company ” or “ Burning Rock ”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will hold its annual |
| 2025-11-20 |
Burning Rock Reports Third Quarter 2025 Financial Results
GUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three |
| 2025-09-24 |
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
TOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech Limited (NASDAQ: BNR, “Burning Rock”) today announced that the OncoGuide™ OncoScreen™ Plus CDx System based on OncoScreen™ Plus to be used as a companion diagnostic for |
| 2025-09-08 |
Burning Rock Reports Second Quarter 2025 Financial Results
GUANGZHOU, China, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three |
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-23 | 2025 Annual General Meeting | Event |
| 2024-12-31 | 2024 Annual General Meeting | Event |
| 2024-05-29 | Burning Rock's 2024 Q1 Earnings Conference Call | Earnings call |
| 2024-03-29 | Burning Rock's 2023 Q4 Earnings Conference Call | Earnings call |
| 2023-12-20 | 2023 Annual General Meeting | Event |
| 2023-11-30 | Burning Rock’s 2023 Q3 Earnings Conference Call | Earnings call |
| 2023-08-31 | Burning Rock’s 2023 Q2 Earnings Conference Call | Earnings call |
| 2023-05-30 | Burning Rock’s 2023 Q1 Earnings Conference Call | Earnings call |
| 2023-03-28 | Burning Rock’s 2022 Q4 Earnings Conference Call | Earnings call |
| 2022-11-16 | Burning Rock’s 2022 Q3 Earnings Conference Call | Earnings call |
Source: https://brbiotech.gcs-web.com/